// App-Quantinova.ai

PB1433 : Analysis of uncharacterised Von Willebrand’s Disease causing mutations located in the D4 and C-domains: identification of a novel type 2A variant and gain-of-function VWF

Researchers

Presenter

  • G. Mobayen

Principal Investigators

  • M. Appiah

  • M. Laffan

  • T. McKinnon

Medical Centers

  • Imperial College, London, United Kingdom

  • Imperial College London, london, England, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • NCRI and Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A